trending Market Intelligence /marketintelligence/en/news-insights/trending/ekHu0idDfgzOgE-k4nkamg2 content esgSubNav
In This List

CTI BioPharma appoints director; 2 board members step down

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


CTI BioPharma appoints director; 2 board members step down

CTI BioPharma Corp. said Phillip Nudelman and Jack Singer resigned as board members.

Their resignations are not due to any disagreement with the company's board or management.

Nudelman stepped down due to health reasons. Singer will remain at CTI BioPharma as executive vice president, chief scientific officer, interim chief medical officer and global head of translational medicine.

Additionally, the company appointed David Parkinson to its board, to serve until the next CTI BioPharma annual shareholder meeting. Parkinson is president and CEO of ESSA Pharma Inc.